Skip to content

Roberto Wandenkolk Vieira, President, Oncology at Corcept Therapeutics, sold CORT on Oct 2, 2026

Data as of Oct 16

▼ SELL$241K2,086 shares at $115.73Roberto Wandenkolk Vieira President, OncologyCORT Corcept Therapeutics Inc
Watch CORT
Traded
Oct 2, 2026
Disclosed
Oct 5, 2026
Filed
3 days after the trade

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

Roberto Wandenkolk Vieira, President, Oncology at Corcept Therapeutics, sold CORT on Oct 2, 2026TRADEDDISCLOSED
CORTSimilar stocks (XLV — its sector index fund), rebased to CORT's price on the disclosure day
CORT since disclosure
−9.7%
after the sale
Similar stocks (XLV) since disclosure
+5.6%
XLV — its sector index fund

Change in closing price from Oct 5, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

Other trades in the same filing

  1. ▼ SELLRoberto Wandenkolk Vieira President, OncologyCORT Corcept Therapeutics Inc$600Kdisclosed Oct 5 · filed 3 days after the trade
  2. ▼ SELLRoberto Wandenkolk Vieira President, OncologyCORT Corcept Therapeutics Inc$126Kdisclosed Oct 5 · filed 3 days after the trade

See every trade on CORT →